Who invested in Carbylan Therapeutics?
Carbylan Therapeutics's investors include InterWest Partners, Alta Partners and Vivo Ventures.
United States · Funded startup
4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Carbylan Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$35Mraised across 4 rounds since 2007, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $4.0M sold, first sale Feb 2015
No investor was named in the report.
From a historical funding recordSEC filing: $5.0M sold, first sale Sept 2014
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Carbylan Therapeutics's investors include InterWest Partners, Alta Partners and Vivo Ventures.
Carbylan Therapeutics has raised $35M across 4 rounds since 2007.
Carbylan Therapeutics's most recent round was a Debt of $4.0M in Mar 2015.
Carbylan Therapeutics's largest round on record is $20M (Series B), in Nov 2007.
Carbylan Therapeutics's first round on record, in Nov 2007, was backed by InterWest Partners, Alta Partners and Vivo Ventures.
Carbylan Therapeutics's latest named round is a Debt, in Mar 2015.
Carbylan Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.